Bloomberg - Oct. 18 (Bloomberg) -- Pfizer Inc., the world's largest drugmaker, said third-quarter profit fell 77 percent on costs for discontinuing its inhaled insulin treatment Exubera. Pfizer said today it wrote off $2.8 billion to abandon Exubera, which didn ...
